現在価格
WuXi PharmaTech (Cayman) Inc. is a leading global contract research and manufacturing organization that provides comprehensive services for the pharmaceutical, biotechnology, and medical device industries. The company sp...|
e.g. Promoter holding
Loading chart...
アナリストによるEPSおよび売上高の予想コンセンサス。
この企業の業績予想は利用できません。
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AACCOM INC | ACMM | — | — | — | — | — | — | — |
| 2. | AActions Se... | ACTS | — | — | — | — | — | — | — |
| 3. | AAegon Fund... | AEFC | — | — | — | — | — | — | — |
| 4. | AFederal Ag... | AGM-P-D | — | — | — | — | — | — | — |
| 5. | AArmada Hof... | AHH-P-A | — | — | — | — | — | — | — |
連結数値(百万円)/単体表示可
| Quarter (M) | Dec 13 | Mar 14 | Jun 14 | Sep 14 | Dec 14 | Mar 15 | Jun 15 | Sep 15 |
|---|---|---|---|---|---|---|---|---|
Revenue | 157.17 | 146.72 | 163.35 | 173.56 | 190.65 | 180.04 | 194.14 | 213.64 |
COGS | 97.5 | 93.09 | 101.82 | 107.37 | 120.26 | 117.23 | 127.44 | 137.75 |
Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit % | - | - | - | - | - | - | - | - |
| 33.55 | 34.59 | 38.37 | 44.16 | 52.11 | 52.19 | 57.33 | 57.09 | |
EBIT | 29.36 | 23.41 | 28 | 27.75 | 24.56 | 16.99 | 17.05 | 25.82 |
OPM % | 18.68% | 15.96% | 17.14% | 15.99% | 12.88% | 9.44% | 8.78% | 12.09% |
Non-Operating Income | 11.37 | -1.72 | 8.01 | 11.51 | 15.09 | 5.04 | 5.82 | -5.3 |
PBT | 40.74 | 21.69 | 36.01 | 39.26 | 39.65 | 22.03 | 22.87 | 20.52 |
Income Tax | 7.88 | 3.87 | 6.67 | 7.26 | 6.65 | 4.25 | 3.42 | 4.45 |
Tax Rate % | 19.35% | 17.84% | 18.53% | 18.49% | 16.78% | 19.27% | 14.96% | 21.7% |
Net Income | 32.86 | 17.82 | 29.34 | 32 | 33 | 17.79 | 18.87 | 15.1 |
NPM % | 20.9% | 12.15% | 17.96% | 18.44% | 17.31% | 9.88% | 9.72% | 7.07% |
連結数値(百万円)/単体表示可
| Period (M) | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 33.78 | 69.94 | 135.21 | 253.49 | 270.02 | 334.06 | 407.18 | 499.91 | 578.08 | 674.28 |
COGS | 13.47 | 31.77 | 63.4 | 126.11 | 137.64 | 174.15 | 216.74 | 275 | 321.78 | 376.18 |
Gross Profit | 20.31 | 38.17 | 71.81 | 127.38 | 132.38 | 159.91 | 190.44 | 224.91 | 256.31 | 298.1 |
Gross Profit % | 60.12% | 54.58% | 53.11% | 50.25% | 49.03% | 47.87% | 46.77% | 44.99% | 44.34% | 44.21% |
| 9.54 | 24.18 | 32.66 | 56.77 | 56.28 | 50.58 | 78.03 | 101.93 | 117.27 | 169.23 | |
EBIT | 8.74 | 10.13 | 30.2 | 39.57 | 52.13 | 80.12 | 83.81 | 89.44 | 105.24 | 103.73 |
OPM % | 25.87% | 14.48% | 22.33% | 15.61% | 19.31% | 23.98% | 20.58% | 17.89% | 18.21% | 15.38% |
Non-Operating Income | -1.54 | -0.88 | 5.21 | 0 | 6.83 | 20.93 | 13.78 | 14.53 | 32.79 | 32.88 |
PBT | 7.2 | 9.25 | 35.4 | 0 | 58.96 | 101.06 | 97.58 | 103.98 | 138.03 | 136.61 |
Income Tax | 1.07 | 0.4 | 1.5 | 0 | 5.53 | 10.24 | 16.61 | 17.39 | 23.46 | 24.45 |
Tax Rate % | 14.92% | 4.3% | 4.23% | - | 9.38% | 10.14% | 17.02% | 16.73% | 17% | 17.9% |
Net Income | 6.13 | 8.85 | 33.9 | 0 | 52.87 | 90.81 | 80.98 | 86.58 | 114.57 | 112.16 |
NPM % | 18.14% | 12.66% | 25.08% | - | 19.58% | 27.18% | 19.89% | 17.32% | 19.82% | 16.63% |
連結数値(百万円)/単体表示可
| Period (M) | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| 4.87 | 9.68 | 213.59 | 56.63 | 80.51 | 115.4 | 71.37 | 54.13 | 88.87 | 211.46 | |
| 0.62 | 2.07 | 5.53 | 15.97 | 23.44 | 40.07 | 130.51 | 175.67 | 305.41 | 224.33 | |
| 22.83 | 42.78 | 73.64 | 152.7 | 181.83 | 205.55 | 245.69 | 264.38 | 279.25 | 351.69 | |
| 4.59 | 12.31 | 24.57 | 20.71 | 24.4 | 32.4 | 60.48 | 66.58 | 76.53 | 80.54 | |
| 7.97 | 18.85 | 26.46 | 90.39 | 97.12 | 104.71 | 156.09 | 181.77 | 198.8 | 313.62 | |
Total Assets | 40.87 | 85.69 | 343.77 | 336.4 | 407.3 | 498.13 | 664.14 | 742.53 | 948.87 | 1,181.63 |
| 4.98 | 4.62 | 9.85 | 10.59 | 11.01 | 11.22 | 11.41 | 11.22 | 11.45 | 11.22 | |
| 12.26 | 43.56 | 241.55 | 220.29 | 269.12 | 381.61 | 494.32 | 567 | 723.3 | 766.63 | |
| 5.04 | 5.76 | 45.09 | 38.17 | 37.98 | 37.72 | 1.65 | 5.7 | 11.12 | 13.99 | |
| 8.39 | 20.93 | 41.51 | 50.54 | 44.02 | 56.54 | 74 | 84.03 | 119.15 | 163.75 | |
| 10.19 | 10.82 | 5.77 | 16.82 | 45.17 | 11.05 | 82.78 | 74.59 | 83.85 | 226.03 | |
Total Liabilities | 40.87 | 85.69 | 343.77 | 336.4 | 407.3 | 498.13 | 664.14 | 742.53 | 948.87 | 1,181.63 |
連結数値(百万円)/単体表示可
| Period (M) | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| 9.06 | 15.33 | 65.23 | 60.66 | 69.77 | 125.65 | 101.06 | 131.06 | 181.51 | 140.38 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 3.58 | 15.54 | 180.49 | 0 | 27.98 | 0 | 29.77 | 0 | 17.93 | 38.14 | |
Net CFNet Cash Flow | 12.63 | 30.87 | 245.72 | 60.66 | 97.76 | 125.65 | 130.84 | 131.06 | 199.44 | 178.52 |
FCFFree Cash Flow | 0.65 | -9 | 25.13 | -2.59 | 14.78 | 76.78 | 37.66 | 64.19 | 128.08 | 42.25 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 27.1% | 22.6% | - | 20.7% | 27.0% | 18.0% | 16.0% | 17.5% | 14.8% | |
| 0.29 | 0.12 | 0.18 | 0.17 | 0.14 | 0.10 | 0.00 | 0.01 | 0.02 | 0.02 | |
| - | - | - | - | - | - | - | - | - | - | |
| - | 1.11 | 0.63 | 0.75 | 0.73 | 0.74 | 0.70 | 0.71 | 0.68 | 0.63 | |
Cash Conversion | 1.48 | 1.73 | 1.92 | - | 1.32 | 1.38 | 1.25 | 1.51 | 1.58 | 1.25 |
Payout Ratio | 27.5% | 76.2% | - | - | - | - | - | - | - | - |
| - | 107.0% | 93.3% | 87.5% | 6.5% | 23.7% | 21.9% | 22.8% | 15.6% | 16.6% | |
| - | - | - | - | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | - | - | - | |
| 4.00 | 5.00 | 3.00 | 3.00 | 4.00 | 6.00 | 4.00 | 5.00 | 4.00 | 4.00 | |
| - | -1.72 | -1.66 | -2.71 | -2.57 | -2.42 | -2.44 | -2.51 | -2.62 | -2.63 | |
| 100.00 | 95.00 | 90.00 | 100.00 | 90.00 | 95.00 | 90.00 | 85.00 | 90.00 | 85.00 | |
| 0.2% | 0.1% | 0.3% | - | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
WuXi PharmaTech Cayman Inc. ADRの株主構成(SEC提出書類より)
Shares sold short · updated twice a month
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 30 Oct 2026 | 456 | +1202.9% | 3.48 | |
| 15 Oct 2026 | 35 | -87.1% | 1.00 | |
| 30 Sep 2026 | 271 | -13.7% | 1.00 | |
| 15 Sep 2026 | 314 | +188.1% | 1.93 | |
| 31 Aug 2026 | 109 | +28.2% | 1.00 | |
| 14 Aug 2026 | 85 | +54.5% | 1.47 | |
| 31 Jul 2026 | 55 | +111.5% | 1.17 | |
| 15 Jul 2026 | 26 | +85.7% | 1.86 | |
| 30 Jun 2026 | 14 | -58.8% | 1.00 | |
| 15 Jun 2026 | 34 | 1.00 |
FINRA consolidated short interest, reported twice a month for every US listing.
WuXi PharmaTech Cayman Inc. ADRのSEC提出書類と決算説明会の議事録
What recent news says about WuXi PharmaTech Cayman Inc. ADR, scored for sentiment.